- Home
- CJET vs ADXN Comparison
CJET vs ADXN Comparison
Compare CJET & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJET
- ADXN
- Stock Information
- Founded
- CJET 2009
- ADXN 2002
- Country
- CJET China
- ADXN Switzerland
- Employees
- CJET N/A
- ADXN N/A
- Industry
- CJET Auto Manufacturing
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CJET Consumer Discretionary
- ADXN Health Care
- Exchange
- CJET Nasdaq
- ADXN Nasdaq
- Market Cap
- CJET 8.3M
- ADXN 8.2M
- IPO Year
- CJET N/A
- ADXN N/A
- Fundamental
- Price
- CJET $1.72
- ADXN $7.10
- Analyst Decision
- CJET
- ADXN Strong Buy
- Analyst Count
- CJET 0
- ADXN 1
- Target Price
- CJET N/A
- ADXN $30.00
- AVG Volume (30 Days)
- CJET 64.8K
- ADXN 7.8K
- Earning Date
- CJET 04-08-2025
- ADXN 04-07-2025
- Dividend Yield
- CJET N/A
- ADXN N/A
- EPS Growth
- CJET N/A
- ADXN N/A
- EPS
- CJET N/A
- ADXN 0.06
- Revenue
- CJET $10,275,000.00
- ADXN $701,260.00
- Revenue This Year
- CJET N/A
- ADXN N/A
- Revenue Next Year
- CJET N/A
- ADXN N/A
- P/E Ratio
- CJET N/A
- ADXN $0.95
- Revenue Growth
- CJET 31.31
- ADXN N/A
- 52 Week Low
- CJET $1.09
- ADXN $6.67
- 52 Week High
- CJET $23.94
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- CJET 56.51
- ADXN 47.07
- Support Level
- CJET $1.36
- ADXN $7.40
- Resistance Level
- CJET $2.06
- ADXN $8.05
- Average True Range (ATR)
- CJET 0.23
- ADXN 0.52
- MACD
- CJET 0.05
- ADXN 0.03
- Stochastic Oscillator
- CJET 63.99
- ADXN 51.22
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.